General information about the research study
When was the study done? Study doctors also collected information about
potential side effects to the vaccines given in this
The study started in April 2018 and ended in study.
March 2020.
Shingles is a disease of the nervous system
caused by shingles virus. Shingles results in fever,
Why was this study done?
headache, chills and upset stomach. Vaccines can
help protect against shingles. Vaccines contain
The main goal of the study was to see if the
parts of shingles virus that cannot cause
immune responses to a shingles vaccine when
infection. These parts help the body make
given together with a pneumococcal vaccine are
defenses, known as antibodies, against the
similar to immune responses when each vaccine
shingles virus.
is given separately
This report focuses on the results of the main
goals of the study. All results may be found in the
clinical results summary.
Who took part in this study?
912 adults from the US, Canada, Germany
and Estonia.
50 years and older when they got their first
vaccination.
543 women (60%)
369 men (40%)
Adults could take part in the study if Adults could not take part in the study if
they: they:
did not have pneumonia infection within the previously received the shingles vaccine
last 5 years from the start of the study, and
previously received any pneumococcal
had never had shingles
vaccine
received any drugs or medicines that may
change their immune response to the study
vaccines